ArticleCommunications biology2022

Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts.

Dennis Gürgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.